Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q87593646)
Watch
English
Afatinib in NSCLC harbouring EGFR mutations
scientific article published on 01 April 2014
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
title
Afatinib in NSCLC harbouring EGFR mutations
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
main subject
non-small-cell lung carcinoma
1 reference
based on heuristic
inferred from title
author
Antonio Passaro
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
author name string
Filippo de Marinis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
Chiara Catania
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
publication date
1 April 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
volume
15
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
page(s)
e148-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
cites work
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970402-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970402-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970402-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970402-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Afatinib for lung cancer: let there be light?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970402-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(13)70402-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
PubMed publication ID
24694632
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24694632
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694632%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
